2013 annual financial data
Capricor Therapeutics 2013 Operating margin
Direct answer
Operating margin was -1,371.73%.
Operating income was -6,903,000 USD and net income was -8,892,000 USD.
Operating cash flow was -6,144,000 USD.
Get free Capricor Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 503,233 USD
- Operating income
- -6,903,000 USD
- Net income
- -8,892,000 USD
- Operating cash flow
- -6,144,000 USD